Potent enzyme inhibitors derived from dromedary heavy-chain antibodies

The EMBO Journal
Marc LauwereysSerge Muyldermans

Abstract

Evidence is provided that dromedary heavy-chain antibodies, in vivo-matured in the absence of light chains, are a unique source of inhibitory antibodies. After immunization of a dromedary with bovine erythrocyte carbonic anhydrase and porcine pancreatic alpha-amylase, it was demonstrated that a considerable amount of heavy-chain antibodies, acting as true competitive inhibitors, circulate in the bloodstream. In contrast, the conventional antibodies apparently do not interact with the enzyme's active site. Next we illustrated that peripheral blood lymphocytes are suitable for one-step cloning of the variable domain fragments in a phage-display vector. By bio-panning, several antigen-specific single-domain fragments are readily isolated for both enzymes. In addition we show that among those isolated fragments active site binders are well represented. When produced as recombinant protein in Escherichia coli, these active site binders appear to be potent enzyme inhibitors when tested in chromogenic assays. The low complexity of the antigen-binding site of these single-domain antibodies composed of only three loops could be valuable for designing smaller synthetic inhibitors.

References

Nov 5, 1992·Journal of Molecular Biology·Z C FanA B Edmundson
Mar 1, 1991·Molecular Immunology·J Novotny
Aug 17, 1990·Biochimica Et Biophysica Acta·E Bibi, R Laskov
Jan 1, 1994·Annual Review of Immunology·G WinterH R Hoogenboom
Feb 1, 1994·Molecular Immunology·E A Padlan
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·T N BhatR J Poljak
May 1, 1993·Proteins·T T WuE A Kabat
Jun 3, 1993·Nature·C Hamers-CastermanR Hamers
Jul 1, 1995·Protein Engineering·K AlfthanT T Teeri
Sep 1, 1996·Nature Structural Biology·S Sheriff, K L Constantine
Sep 1, 1996·Nature Structural Biology·S SpinelliM Tegoni
Dec 1, 1996·Protein Science : a Publication of the Protein Society·R A LaskowskiJ M Thornton
Sep 1, 1996·Immunotechnology : an International Journal of Immunological Engineering·J Davies, L Riechmann
Feb 19, 1998·Journal of Molecular Biology·V K NguyenR Hamers
May 5, 1998·Molecular Immunology·K B VuS Muyldermans
May 1, 1995·Bio/technology·J Davies, L Riechmann

❮ Previous
Next ❯

Citations

Jul 9, 1999·Journal of Molecular Recognition : JMR·S Muyldermans, M Lauwereys
Dec 28, 1999·Journal of Molecular Recognition : JMR·D G Myszka
Mar 29, 2002·International Journal of Cancer. Journal International Du Cancer·Virna Cortez-RetamozoHilde Revets
Apr 8, 2010·Analytical and Bioanalytical Chemistry·Katrin SchmidthalsHeinrich Leonhardt
Jan 13, 2006·Cancer Metastasis Reviews·Mehdi Arbabi-GhahroudiRoger MacKenzie
Oct 29, 2009·Transgenic Research·Yi-Hui Audrey Teh, Tony A Kavanagh
Dec 23, 2003·Journal of Molecular Biology·Juan Fernández-RecioRuben Abagyan
Jul 17, 2013·Protein Expression and Purification·Valencio Salema, Luis Ángel Fernández
Oct 24, 2003·Trends in Biotechnology·Lucy J HoltIan M Tomlinson
Feb 6, 2004·Toxicon : Official Journal of the International Society on Toxinology·Fatma Meddeb-MouelhiMohamed El Ayeb
Jun 16, 2000·Journal of Immunological Methods·R van der LindenL Frenken
May 16, 2002·Journal of Immunological Methods·Jamshid TanhaC Roger MacKenzie
Jan 29, 2000·Journal of Immunological Methods·L Riechmann, S Muyldermans
Jan 25, 2003·Developmental and Comparative Immunology·K E ConrathV K Nguyen
Apr 21, 1999·Biochimica Et Biophysica Acta·R H van der LindenC T Verrips
Sep 1, 2000·Advanced Drug Delivery Reviews·F NilssonD Neri
Aug 31, 2001·Journal of Biotechnology·S Muyldermans
Apr 13, 2010·Parasitology·Magdalena Radwanska
Mar 23, 2012·Animal : an International Journal of Animal Bioscience·A FerrariJ Leoni
Apr 9, 2009·Nature Biotechnology·Aaron L Nelson, Janice M Reichert
Dec 17, 2002·Nature Biotechnology·Stephen A JoblingMartine E Verhoeyen
Nov 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sven JähnichenMartine J Smit
Sep 21, 2011·Proceedings of the National Academy of Sciences of the United States of America·Benoît-Joseph LaventieDubravka Drabek
Jan 23, 2010·The Journal of Biological Chemistry·Jeeraphong ThanongsaksrikulWanpen Chaicumpa
Apr 20, 2010·The Journal of Biological Chemistry·Willie W L KohRobin A Weiss
Dec 1, 2011·The Journal of Biological Chemistry·Jochen GovaertDirk Saerens
Dec 19, 2007·The Journal of Experimental Medicine·Xiangang ZouMarianne Brüggemann
Aug 18, 2004·Hybridoma and Hybridomics·F RahbarizadehE Sadroddiny
Oct 13, 2006·Antioxidants & Redox Signaling·Pamela Maher
Jul 1, 2008·Briefings in Functional Genomics & Proteomics·Dirk SaerensSerge Muyldermans
Jun 30, 2009·International Immunology·Louise S MathesonMarianne Brüggemann
Jun 2, 2006·Nucleic Acids Research·Fred P DavisM S Madhusudhan
Feb 7, 2009·Protein Engineering, Design & Selection : PEDS·Ana MonegalArio de Marco
Dec 9, 2010·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Romany N N AbskharonAlexandre Wohlkonig
Feb 16, 2002·Protein Science : a Publication of the Protein Society·Mireille DumoulinAndre Matagne
Dec 14, 1999·Protein Science : a Publication of the Protein Society·P Wirtz, B Steipe
Sep 15, 2001·Antimicrobial Agents and Chemotherapy·K E ConrathS Muyldermans

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.